Aspirin 500 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule — RxCUI 2583731
RxNorm drug concept · Semantic clinical drug
RxCUI 2583731
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2583731
Official nameAspirin 500 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asASA 500 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Aspirin, Butalbital, and Caffeine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This medicine is specifically approved to treat tension headaches — the kind caused by muscle tightness in your head, neck, and shoulders, often with a feeling of stress or pressur...
- What exactly is this medicine for? I heard it's for headaches — is it for migraines too?
- That's actually something to be careful about. This medicine is not recommended for long-term or repeated use. One of the ingredients — butalbital — is habit-forming and can lead t...
- Can I take this every day if my headaches keep coming back?
🕸️ Concept Web — How Aspirin 500 MG / butalbital 50 MG / caffeine 40... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Aspirin 500 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule
RxCUI 2583731 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Aspirin
1191IN -
Butalbital
19860IN -
Caffeine
1886IN -
Aspirin / butalbital / caffeine
282422MIN
-
Aspirin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Aspirin / butalbital / caffeine Oral Capsule
374753SCDF -
Aspirin / butalbital / caffeine Oral Product
1154060SCDG -
Aspirin / butalbital / caffeine Pill
1154061SCDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Aspirin / butalbital / caffeine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Aspirin 500 MG
315424SCDC -
Butalbital 50 MG
317309SCDC -
Caffeine 40 MG
317310SCDC
-
Aspirin 500 MG
Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Aspirin 500 MG
SCDC · 315424 -
Butalbital 50 MG
SCDC · 317309 -
Caffeine 40 MG
SCDC · 317310 -
Aspirin / butalbital / caffeine Oral Capsule
SCDF · 374753 -
Aspirin / butalbital / caffeine Oral Product
SCDG · 1154060 -
Aspirin / butalbital / caffeine Pill
SCDG · 1154061
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 2583731 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 79739-7192-01 | 100 CAPSULE in 1 BOTTLE (79739-7192-1) | Butalbital, Aspirin, and Caffeine | LGM PHARMA SOLUTIONS, LLC | 2021-10-18 |
| 79739-7192-05 | 500 CAPSULE in 1 BOTTLE (79739-7192-5) | Butalbital, Aspirin, and Caffeine | LGM PHARMA SOLUTIONS, LLC | 2021-10-18 |
Observed labelers:
LGM PHARMA SOLUTIONS, LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.